CREMETRSBI DL-001 Valuation
| WY52 Stock | EUR 1.70 0.00 0.00% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. CREMECOMTRSBI DL 001 shows a prevailing Real Value of €1.83 per share. The current price of the firm is €1.7. Our model approximates the value of CREMECOMTRSBI DL 001 from reviewing the firm fundamentals such as Shares Outstanding of 22.74 M, return on equity of 0.014, and Profit Margin of 0.06 % as well as analyzing its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that CREMETRSBI DL-001's price fluctuation is extremely dangerous at this time. Calculation of the real value of CREMECOMTRSBI DL 001 is based on 3 months time horizon. Increasing CREMETRSBI DL-001's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the CREMETRSBI stock is determined by what a typical buyer is willing to pay for full or partial control of CREMECOMTRSBI DL 001. Since CREMETRSBI DL-001 is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CREMETRSBI Stock. However, CREMETRSBI DL-001's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.7 | Real 1.83 | Hype 1.7 | Naive 1.73 |
The real value of CREMETRSBI Stock, also known as its intrinsic value, is the underlying worth of CREMECOMTRSBI DL 001 Company, which is reflected in its stock price. It is based on CREMETRSBI DL-001's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of CREMETRSBI DL-001's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of CREMECOMTRSBI DL 001 helps investors to forecast how CREMETRSBI stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CREMETRSBI DL-001 more accurately as focusing exclusively on CREMETRSBI DL-001's fundamentals will not take into account other important factors: CREMETRSBI DL-001 Total Value Analysis
CREMECOMTRSBI DL 001 is at this time forecasted to have takeover price of 0 with market capitalization of 115.29 M, debt of 260.72 M, and cash on hands of 59.73 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the CREMETRSBI DL-001 fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
0 | 115.29 M | 260.72 M | 59.73 M |
CREMETRSBI DL-001 Investor Information
About 13.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 0.65. CREMECOMTRSBI DL 001 last dividend was issued on the 23rd of December 2022. The entity had 10:1 split on the 5th of November 2024. Based on the key measurements obtained from CREMETRSBI DL-001's financial statements, CREMECOMTRSBI DL 001 is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.CREMETRSBI DL-001 Asset Utilization
One of the ways to look at asset utilization of CREMETRSBI is to check how much profit was generated for every dollar of assets it reports. CREMECOMTRSBI DL 001 utilizes its assets nearly 0.0151 percent, getting 0.0151 cents for each euro of assets held by the firm. An expanding asset utilization signifies that the company is being more capable with each euro of assets it shows. Put another way, asset utilization of CREMETRSBI DL-001 shows how capable it operates for each euro spent on its assets.CREMETRSBI DL-001 Ownership Allocation
CREMETRSBI DL-001 holds a total of 22.74 Million outstanding shares. Over half of CREMETRSBI DL-001's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Thus, these institutions are subject to different rules and regulations than regular investors in CREMETRSBI DL-001. Please watch out for any change in the institutional holdings of CREMECOMTRSBI DL 001 as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.CREMETRSBI DL-001 Profitability Analysis
The company reported the revenue of 101.34 M. Net Loss for the year was (30.95 M) with profit before overhead, payroll, taxes, and interest of 42.62 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates CREMETRSBI DL-001's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in CREMETRSBI DL-001 and how it compares across the competition.
About CREMETRSBI DL-001 Valuation
The stock valuation mechanism determines CREMETRSBI DL-001's current worth on a weekly basis. Our valuation model uses a comparative analysis of CREMETRSBI DL-001. We calculate exposure to CREMETRSBI DL-001's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CREMETRSBI DL-001's related companies.CIM Commercial is a real estate investment trust that primarily acquires, owns, and operates Class A and creative office assets in vibrant and improving metropolitan communities throughout the United States . CIM Commercial is operated by affiliates of CIM Group, L.P., a vertically-integrated owner and operator of real assets with multi-disciplinary expertise and in-house research, acquisition, credit analysis, development, finance, leasing, and onsite property management capabilities. CIM COMM operates under REITOffice classification in Germany and is traded on Frankfurt Stock Exchange. It employs 4 people.
8 Steps to conduct CREMETRSBI DL-001's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates CREMETRSBI DL-001's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct CREMETRSBI DL-001's valuation analysis, follow these 8 steps:- Gather financial information: Obtain CREMETRSBI DL-001's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine CREMETRSBI DL-001's revenue streams: Identify CREMETRSBI DL-001's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research CREMETRSBI DL-001's industry and market trends, including the size of the market, growth rate, and competition.
- Establish CREMETRSBI DL-001's growth potential: Evaluate CREMETRSBI DL-001's management, business model, and growth potential.
- Determine CREMETRSBI DL-001's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate CREMETRSBI DL-001's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for CREMETRSBI Stock analysis
When running CREMETRSBI DL-001's price analysis, check to measure CREMETRSBI DL-001's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CREMETRSBI DL-001 is operating at the current time. Most of CREMETRSBI DL-001's value examination focuses on studying past and present price action to predict the probability of CREMETRSBI DL-001's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CREMETRSBI DL-001's price. Additionally, you may evaluate how the addition of CREMETRSBI DL-001 to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |